drugset / Trial / NCT01110668
Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
NaSingle-groupOpen-labelTreatment
Summary
This study will assess time-to-disease progression in patients with advanced gastrointestinal stromal tumor (GIST) previously treated with imatinib ≥600 mg.
Timeline
- Start
- 2008-09
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nilotinib | Small molecule | — | — |